Disorders of mood and affect in multiple sclerosis

Multiple Sclerosis: Recovery of Function and Neurorehabilitation

Volumn , Issue , 2010, Pages 183-189

  Feinstein, Anthony ^a   Ghaffar, Omar ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856931313     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511781698.022     Document Type: Chapter

References (53)

1. American Psychiatric Association. Diagnostic and statistical manual. 4th ed. Washington, DC: American Psychiatric Press, 1994
2. Feinstein A, Feinstein KJ. Depression associated with multiple sclerosis: looking beyond diagnosis to symptom expression. J Affect Disord 2001;66:193–8
3. Minden S L, Orav J, Reich P. Depression in multiple sclerosis. Gen Hosp Psychiatry 1987;9:426–34
4. Joffe R T, Lippert G P, Gray TA, Sawa G, Horvath Z. Mood disorder and multiple sclerosis. Arch Neurol 1987;44:376–8
5. Sadovnik A N, Remick R A, Allen J, et al. Depression and multiple sclerosis. Neurology 1996;46:628–32
6. Patten S B, Beck C A, Williams J V A, Barbui C, Metz L M. Major depression in multiple sclerosis: a population-based perspective. Neurology 2003;61:1524–7
7. Zigmond A S, Snaith R P. The Hospital and Anxiety Depression Scale. Acta Psychiatr Scand 1983;67:361–70
8. Beck A T, Steer R A, Brown G K. BDI-Fast Screen for Medical Patients manual. San Antonio, TX: The Psychological Corporation, 2000.
9. Benedict RH, Fishman I, McClellan MM, Bakshi R, Weinstock-Guttman B. Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Mult Scler 2003;9:393–6
10. Feinstein A, O’Connor P, Gray T, Feinstein K. The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult Scler 1999;5:323–6
11. Quesnel S, Feinstein A. Multiple sclerosis and alcohol: a study of problemdrinking. Mult Scler 2004;10:197–201
12. Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 2007;13:67–72
13. Stenager E N, Stenager E, Koch-Hendrikson N, et al. Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry 1992;55:542–5
14. Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology 2002;59:674–8
15. Patten S B, Metz L M, Reimer M A. Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population. Mult Scler 2000;6:115–20
16. Schiffer R B, Caine ED, Bamford K A, Levy S. Depressive episodes in patients with multiple sclerosis. Am J Psychiatry 1983;140:1498–500
17. Pujol J, Bello J, Deus J, Marti-Vilalta J L, Capdevila A. Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 1997;49:1105–10
18. Berg D, Supprian T, Thomae J, et al. Lesion pattern in patients with multiple sclerosis and depression. Mult Scler 2000;6:156–62
19. Bakshi R, Czarnecki D, Shaikh ZA, et al. Brain MRI lesions and atrophy are related to depression in multiple sclerosis. NeuroReport 2000;11:1153–8
20. Feinstein A, Roy P, Lobaugh N, Feinstein K J, O’Connor P. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004;62:586–90
21. Moradzadeh L, Feinstein A, Lobaugh N, Ramirez J. Multiple sclerosis and depression: a diffusion MRI study. (Abstract.) J Neuropsychiatry Clin Neurosci 2007;19:232
22. Lynch SG, Kroencke DC, Denney DR. The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping and hope. Mult Scler 2001;7:411–16
23. Mohr D C, Goodkin D E, Gatto N, van der Wende J. Depression, coping and level of neurological impairment in multiple sclerosis. Mult Scler 1997;3:254–8
24. Pakenham K I. Adjustment to multiple sclerosis: application of a stress coping model. Health Psychol 1999;18:383–92
25. Shnek Z M, Foley F W, LaRocca N G, et al. Helplessness, self-efficacy, cognitive distortions, and depression in multiple sclerosis and spinal cord injury. Ann Behav Med 1997;19:287–94
26. Maybury C P, Brewin C R. Social relationships, knowledge and adjustment to multiple sclerosis. J Neurol Neurosurg Psychiatry 1984;47:372–6
27. Voss W D, Arnett P A, Higginson C I, et al. Contributing factors to depressed mood in multiple sclerosis. Arch Clin Neuropsychol 2002;17:103–15
28. Schiffer R B, Wineman N M. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 1990;147:1493–7
29. Scott T F, Nussbaum P, McConnell H, Brill P. Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale. Neurol Res 1995;17:421–2
30. Barak Y, Ur E, Archiron A. Moclobemide treatment in multiple sclerosis patients with co-morbid depression: an open label safety trial. J Neuropsychiatry Clin Neurosci 1999;11:271–3
31. Mohr D C, Boudewyn A C, Goodkin D, Bostrom A, Epstein L. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group therapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 2001;69:942–9
32. Mohr D C, Likosky W, Bertagnoli A, et al. Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis. J Consult Clin Psychol 2000;68:356–61
33. Mattingley G, Baker K, Zorumski CF, Figiel GS. Multiple sclerosis and ECT: possible value of gadolinium enhanced magnetic resonance scans for identifying high risk patients. J Neuropsychiatry Clin Neurosci 1992;4:145–51
34. Schiffer R B, Wineman M, Weitkamp L R. Association between bipolar affective disorder and multiple sclerosis. Am J Psychiatry 1986;143:94–5
35. Minden S L, Orav J, Schildkraut J J. Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology 1988;38:1631–4
36. Reischies F M, Baum K, Bräu H, Hedde J P, Schwindt G. Cerebral magnetic resonance imaging findings in multiple sclerosis: relation to disturbance of affect, drive and cognition. Arch Neurol 1988;45:1114–16
37. Feinstein A, Du Boulay G, Ron M A. Psychotic illness in multiple sclerosis: a clinical and magnetic resonance imaging study. Br J Psychiatry 1992;161:680–5
38. Cottrell S S, Wilson S A K. The affective symptomatology of disseminated sclerosis. J Neurol Psychopath 1926;7:1–30
39. Rabins P V. Euphoria in multiple sclerosis. In: Rao S M, ed. Neurobehavioral aspects of multiple sclerosis. New York: Oxford University Press, 1990:180–5
40. Fishman I, Benedict R H B, Bakshi R, Priore R, Weinstock-Guttman B. Construct validity and frequency of euphoria sclerotica in multiple sclerosis. J Neuropsychiatry Clin Neurosci 2004;16:350–6
41. Diaz-Olavarrieta C, Cummings J L, Velasquez J, Garcia de la Cadena C. Neuropsychiatric manifestations of multiple sclerosis. J Neuropsychiatry Clin Neurosci 1999;11:51–7
42. Rabins P V, Brooks B R, O’Donnell O P, et al. Structural brain correlates of emotional disorder in multiple sclerosis. Brain 1986;109:585–97
43. Ron M A, Logsdail S J. Psychiatric morbidity in multiple sclerosis: a clinical and MRI study. Psychol Med 1989;19:887–95
44. Cummings J L, Arcinegas DB, Brooks B R, et al. Defining and diagnosing involuntary emotional expression disorder. CNS Specr 2006;11:1–7
45. Feinstein A, Feinstein KJ, Gray T, O’Connor P. The prevalence and neurobehavioral correlates of pathological laughter and crying in multiple sclerosis. Arch Neurol 1997;54:1116–21
46. Feinstein A, O’Connor P, Gray T, Feinstein K. Pathological laughing and crying in multiple sclerosis: a preliminary report suggesting a role for the prefrontal cortex. Mult Scler 1999;5:69–73
47. Ghaffar O, Chamelian L, Feinstein A. Neuroanatomy of pseudobulbar affect: a quantitative MRI study in multiple sclerosis. J Neurol 2008;255:406–12
48. Sakheim H A, Greenberg M S, Weinman A L, et al. Hemisphere asymmetry in the expression of positive and negative emotions. Arch Neurol 1982;39:210–18
49. Schiffer R B, Herndon R M, Rudick R A. Treatment of pathologic laughing and weeping with amitriptyline. New Engl J Med 1985;312:1480–2
50. Seliger G M, Hornstein A, Flax J, Herbert J, Schroder K. Fluoxetine improves emotional incontinence. Brain Inj 1992;6:267–70
51. Udaka F, Yamao S, Nagata H, Nakamura S, Kameyama M. Pathologic laughing and crying treated with levodopa. Arch Neurol 1984;41:1095–6
52. Panitch H S, Thisted R A, Smith R A, et al. Randomized controlled trial of dextromethorphan/quinidine for pseudobulbar effect in multiple sclerosis. Ann Neurol 2006;59:780–7
53. Goldman Consensus Group. The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler 2005;11:328–37